Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 85

1.

SEQUELAE OF PATIENTS TREATED FOR PULMONARY TUBERCULOSIS IN CHEST CLINIC, TIKUR ANBESSA SPECIALIZED HOSPITAL (TASH), ADDIS ABABA, ETHIOPIA.

Binegdie AB, Parekh M, Tolessa TB, Ahmed FO, Sherman CB, Ethel JC, Schluger NW.

Ethiop Med J. 2015 Oct;53(4):167-71.

PMID:
27182582
2.

The East African Training Initiative. A Model Training Program in Pulmonary and Critical Care Medicine for Low-Income Countries.

Sherman CB, Carter EJ, Braendli O, Getaneh A, Schluger NW.

Ann Am Thorac Soc. 2016 Apr;13(4):451-5. doi: 10.1513/AnnalsATS.201510-673OC.

PMID:
26991950
3.

Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.

Bliven-Sizemore EE, Sterling TR, Shang N, Benator D, Schwartzman K, Reves R, Drobeniuc J, Bock N, Villarino ME; TB Trials Consortium.

Int J Tuberc Lung Dis. 2015 Sep;19(9):1039-44, i-v. doi: 10.5588/ijtld.14.0829.

PMID:
26260821
4.

Notes from the field. Training pulmonary specialists in a low-income country.

Schluger NW, Sherman C.

Ann Am Thorac Soc. 2015 Apr;12(4):467-8. doi: 10.1513/AnnalsATS.201502-103ED. No abstract available.

PMID:
25897740
5.

National trends in emergency room diagnosis of pulmonary embolism, 2001-2010: a cross-sectional study.

Schissler AJ, Rozenshtein A, Schluger NW, Einstein AJ.

Respir Res. 2015 Mar 24;16:44. doi: 10.1186/s12931-015-0203-9.

6.

Variability in interferon gamma release assay results and screening for tuberculosis. A way forward?

Schluger NW, Burzynski J.

Ann Am Thorac Soc. 2014 Oct;11(8):1256-7. doi: 10.1513/AnnalsATS.201408-361ED. No abstract available.

PMID:
25343196
7.

The electronic cigarette: a knight in shining armour or a Trojan horse?

Schluger NW.

Psychiatr Bull (2014). 2014 Oct;38(5):201-3. doi: 10.1192/pb.bp.114.048439.

8.

The growing challenge of nontuberculous mycobacteria.

Schluger NW.

Chest. 2014 Sep;146(3):529-30. doi: 10.1378/chest.14-0279. No abstract available.

PMID:
25180714
9.

Update in tuberculosis and nontuberculous mycobacterial infections 2013.

Reves R, Schluger NW.

Am J Respir Crit Care Med. 2014 Apr 15;189(8):894-8. doi: 10.1164/rccm.201402-0210UP. Review. No abstract available.

PMID:
24735031
10.

Lung disease in a global context. A call for public health action.

Schluger NW, Koppaka R.

Ann Am Thorac Soc. 2014 Mar;11(3):407-16. doi: 10.1513/AnnalsATS.201312-420PS.

PMID:
24673697
11.

Long walk to treatment for XDR tuberculosis in South Africa.

O'Donnell MR, Schluger NW.

Lancet. 2014 Apr 5;383(9924):1193-4. doi: 10.1016/S0140-6736(14)60043-X. Epub 2014 Jan 17. No abstract available.

PMID:
24439236
12.

Fluoroquinolones in the treatment of tuberculosis: which is best?

Schluger NW.

Am J Respir Crit Care Med. 2013 Oct 1;188(7):768-9. doi: 10.1164/rccm.201308-1446ED. No abstract available.

PMID:
24083858
13.

Treatment of latent tuberculosis infection.

Parekh MJ, Schluger NW.

Ther Adv Respir Dis. 2013 Dec;7(6):351-6. doi: 10.1177/1753465813503028. Epub 2013 Sep 20. Review.

PMID:
24056289
14.

High burden of palliative needs among older intensive care unit survivors transferred to post-acute care facilities. a single-center study.

Baldwin MR, Wunsch H, Reyfman PA, Narain WR, Blinderman CD, Schluger NW, Reid MC, Maurer MS, Goldstein N, Lederer DJ, Bach P.

Ann Am Thorac Soc. 2013 Oct;10(5):458-65. doi: 10.1513/AnnalsATS.201303-039OC.

15.

Tuberculosis, drug use and HIV infection in Central Asia: an urgent need for attention.

Schluger NW, El-Bassel N, Hermosilla S, Terlikbayeva A, Darisheva M, Aifah A, Galea S.

Drug Alcohol Depend. 2013 Nov;132 Suppl 1:S32-6. doi: 10.1016/j.drugalcdep.2013.07.012. Epub 2013 Aug 6. Review.

PMID:
23928052
16.

CT pulmonary angiography: increasingly diagnosing less severe pulmonary emboli.

Schissler AJ, Rozenshtein A, Kulon ME, Pearson GD, Green RA, Stetson PD, Brenner DJ, D'Souza B, Tsai WY, Schluger NW, Einstein AJ.

PLoS One. 2013 Jun 12;8(6):e65669. doi: 10.1371/journal.pone.0065669. Print 2013.

17.

A prognostic model for 6-month mortality in elderly survivors of critical illness.

Baldwin MR, Narain WR, Wunsch H, Schluger NW, Cooke JT, Maurer MS, Rowe JW, Lederer DJ, Bach PB.

Chest. 2013 Apr;143(4):910-9. doi: 10.1378/chest.12-1668.

18.

Advances in the diagnosis of latent tuberculosis infection.

Schluger NW.

Semin Respir Crit Care Med. 2013 Feb;34(1):60-6. doi: 10.1055/s-0032-1333545. Epub 2013 Mar 4. Review.

PMID:
23460006
19.

Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter?

Schluger NW.

Am J Respir Crit Care Med. 2012 Oct 15;186(8):710-1. doi: 10.1164/rccm.201208-1478ED. No abstract available.

PMID:
23071188
20.

Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.

Dorman SE, Goldberg S, Stout JE, Muzanyi G, Johnson JL, Weiner M, Bozeman L, Heilig CM, Feng PJ, Moro R, Narita M, Nahid P, Ray S, Bates E, Haile B, Nuermberger EL, Vernon A, Schluger NW; Tuberculosis Trials Consortium.

J Infect Dis. 2012 Oct 1;206(7):1030-40. Epub 2012 Jul 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk